L-Sox5 and Sox6 Drive Expression of the Aggrecan Gene in Cartilage by Securing Binding of Sox9 to a Far-Upstream Enhancer

REFERENCES

• Akiyama, H. 20 March 2008. Control of chondrogenesis by the transcription factor Sox9. Mod. Rheumatol. 18:213–219.
   PubMed Web of Science ®Google Scholar
• Akiyama, H., M. C. Chaboissier, J. E. Martin, A. Schedl, and B. de Crombrugghe. 2002. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 16:2813–2828.
   PubMed Web of Science ®Google Scholar
• Akiyama, H., J. P. Lyons, Y. Mori-Akiyama, X. Yang, R. Zhang, Z. Zhang, J. M. Deng, M. M. Taketo, T. Nakamura, R. R. Behringer, P. D. McCrea, and B. de Crombrugghe. 2004. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev. 18:1072–1087.
   PubMed Web of Science ®Google Scholar
• Bell, D. M., K. K. Leung, S. C. Wheatley, L. J. Ng, S. Zhou, K. W. Ling, M. H. Sham, P. Koopman, P. P. Tam, and K. S. Cheah. 1997. SOX9 directly regulates the type-II collagen gene. Nat. Genet. 16:174–178.
   PubMed Web of Science ®Google Scholar
• Bi, W., J. M. Deng, Z. Zhang, R. R. Behringer, and B. de Crombrugghe. 1999. Sox9 is required for cartilage formation. Nat. Genet. 22:85–89.
   PubMed Web of Science ®Google Scholar
• Bridgewater, L. C., V. Lefebvre, and B. de Crombrugghe. 1998. Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer. J. Biol. Chem. 273:14998–15006.
   PubMed Web of Science ®Google Scholar
• Bridgewater, L. C., M. D. Walker, G. C. Miller, T. A. Ellison, L. D. Holsinger, J. L. Potter, T. L. Jackson, R. K. Chen, V. L. Winkel, Z. Zhang, S. McKinney, and B. de Crombrugghe. 2003. Adjacent DNA sequences modulate Sox9 transcriptional activation at paired Sox sites in three chondrocyte-specific enhancer elements. Nucleic Acids Res. 31:1541–1553.
   PubMed Web of Science ®Google Scholar
• Denny, P., S. Swift, F. Connor, and A. Ashworth. 1992. An SRY-related gene expressed during spermatogenesis in the mouse encodes a sequence-specific DNA-binding protein. EMBO J. 11:3705–3712.
   PubMedGoogle Scholar
• Doege, K., L. B. Hall, W. McKinnon, L. Chen, D. T. Stephens, and K. A. Garrison. 2002. A remote upstream element regulates tissue-specific expression of the rat aggrecan gene. J. Biol. Chem. 277:13989–13997.
   PubMedGoogle Scholar
• Doege, K. J., K. Garrison, S. N. Coulter, and Y. Yamada. 1994. The structure of the rat aggrecan gene and preliminary characterization of its promoter. J. Biol. Chem. 269:29232–29240.
   PubMedGoogle Scholar
• Dumitriu, B., P. Dy, P. Smits, and V. Lefebvre. 2006. Generation of mice harboring a Sox6 conditional null allele. Genesis 44:219–224.
   PubMedGoogle Scholar
• Dy, P., A. Penzo-Méndez, H. Wang, C. E. Pedraza, W. B. Macklin, and V. Lefebvre. 2008. The three SoxC proteins—Sox4, Sox11, and Sox12—exhibit overlapping expressing patterns and molecular properties. Nucleic Acids Res. 36:3101–3117.
   PubMed Web of Science ®Google Scholar
• Dy, P., Y. Han, and V. Lefebvre. 2008. Generation of mice harboring a Sox5 conditional null allele. Genesis 46:294–299.
   PubMedGoogle Scholar
• Eyre, D. R. 2004. Collagens and cartilage matrix homeostasis. Clin. Orthop. Relat. Res. 427:118–122.
   PubMed Web of Science ®Google Scholar
• Genzer, M. A., and L. C. Bridgewater. 2007. A Col9a1 enhancer element activated by two interdependent SOX9 dimers. Nucleic Acids Res. 35:1178–1186.
   PubMed Web of Science ®Google Scholar
• Gleghorn, L., R. Ramesar, P. Beighton, and G. Wallis. 2005. A mutation in the variable repeat region of the aggrecan gene (AGC1) causes a form of spondyloepiphyseal dysplasia associated with severe, premature osteoarthritis. Am. J. Hum. Genet. 77:484–490.
   PubMedGoogle Scholar
• Goldring, M. B., and S. R. Goldring. 2007. Osteoarthritis. J. Cell. Physiol. 213:626–634.
   PubMed Web of Science ®Google Scholar
• Hogan, B., R. Beddington, F. Costantini, and E. Lacy. 1994. Manipulating the mouse embryo, p. 373-375. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
   Google Scholar
• Horton, W. E., Jr., M. Lethbridge-Cejku, M. C. Hochberg, R. Balakir, P. Precht, C. C. Plato, J. D. Tobin, L. Meek, and K. Doege. 1998. An association between an aggrecan polymorphic allele and bilateral hand osteoarthritis in elderly white men: data from the Baltimore Longitudinal Study of Aging (BLSA). Osteoarthritis Cartilage 6:245–251.
   PubMedGoogle Scholar
• Ikeda, T., S. Kamekura, A. Mabuchi, I. Kou, S. Seki, T. Takato, K. Nakamura, H. Kawaguchi, S. Ikegawa, and U. I. Chung. 2004. The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum. 50:3561–3573.
   PubMed Web of Science ®Google Scholar
• Kimata, K., H. J. Barrach, K. S. Brown, and J. P. Pennypacker. 1981. Absence of proteoglycan core protein in cartilage from the cmd/cmd (cartilage matrix deficiency) mouse. J. Biol. Chem. 256:6961–6968.
   PubMed Web of Science ®Google Scholar
• Kou, I., and S. Ikegawa. 2004. SOX9-dependent and -independent transcriptional regulation of human cartilage link protein. J. Biol. Chem. 279:50942–50948.
   PubMed Web of Science ®Google Scholar
• Krebsbach, P. H., K. Nakata, S. M. Bernier, O. Hatano, T. Miyashita, C. S. Rhodes, and Y. Yamada. 1996. Identification of a minimum enhancer sequence for the type II collagen gene reveals several core sequence motifs in common with the link protein gene. J. Biol. Chem. 271:4298–4303.
   PubMedGoogle Scholar
• Lefebvre, V., B. Dumitriu, A. Penzo-Mendez, Y. Han, and B. Pallavi. 2007. Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors. Int. J. Biochem. Cell Biol. 39:2195–2214.
   PubMed Web of Science ®Google Scholar
• Lefebvre, V., S. Garofalo, G. Zhou, M. Metsäranta, E. Vuorio, and B. De Crombrugghe. 1994. Characterization of primary cultures of chondrocytes from type II collagen/beta-galactosidase transgenic mice. Matrix Biol. 14:329–335.
   PubMedGoogle Scholar
• Lefebvre, V., W. Huang, V. R. Harley, P. N. Goodfellow, and B. de Crombrugghe. 1997. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro-alpha 1(II) collagen gene. Mol. Cell. Biol. 17:2336–2346.
   PubMed Web of Science ®Google Scholar
• Lefebvre, V., P. Li, and B. de Crombrugghe. 1998. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are co-expressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J. 17:5718–5733.
   PubMed Web of Science ®Google Scholar
• Lefebvre, V., and P. Smits. 2005. Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res. Part C Embryo Today Rev. 75:200–212.
   PubMedGoogle Scholar
• Lefebvre, V., G. Zhou, K. Mukhopadhyay, C. N. Smith, Z. Zhang, H. Eberspaecher, X. Zhou, S. Sinha, S. N. Maity, and B. de Crombrugghe. 1996. An 18-base-pair sequence in the mouse proα1(II) collagen gene is sufficient for expression in cartilage and binds nuclear proteins that are selectively expressed in chondrocytes. Mol. Cell Biol. 16:4512–4523.
   PubMed Web of Science ®Google Scholar
• Li, H., and N. B. Schwartz. 1995. Gene structure of chick cartilage chondroitin sulfate proteoglycan (aggrecan) core protein. J. Mol. Evol. 41:878–885.
   PubMedGoogle Scholar
• Liu, C. J., Y. Zhang, K. Xu, D. Parsons, D. Alfonso, and P. E. Di Cesare. 2007. Transcriptional activation of cartilage oligomeric matrix protein by Sox9, Sox5, and Sox6 transcription factors and CBP/p300 coactivators. Front. Biosci. 12:3899–3910.
   PubMedGoogle Scholar
• Mertin, S., S. G. McDowall, and V. R. Harley. 1999. The DNA-binding specificity of SOX9 and other SOX proteins. Nucleic Acids Res. 27:1359–1364.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay, K., V. Lefebvre, G. Zhou, S. Garofalo, J. H. Kimura, and B. de Crombrugghe. 1995. Use of a new rat chondrosarcoma cell line to delineate a 119-bp chondrocyte-specific enhancer element and to define active promoter segments in the mouse pro-alpha 1(II) collagen gene. J. Biol. Chem. 270:27711–27729.
   PubMedGoogle Scholar
• Nakamura, E., M.-T. Nguyen, and S. Mackem. 2006. Kinetics of tamoxifen-regulated Cre activity in mice using a cartilage-specific CreER™ to assay temporal activity windows along the proximo-distal limb skeleton. Dev. Dyn. 235:2603–2612.
   PubMed Web of Science ®Google Scholar
• Ng, L.-J., S. Wheatley, G. E. O. Muscat, J. Conway-Campbell, J. Bowles, E. Wright, D. M. Bell, P. P. L. Tam, K. S. E. Cheah, and P. Koopman. 1997. SOX9 binds DNA, activates transcription, and coexpressed with type II collagen during chondrogenesis in the mouse. Dev. Biol. 183:108–121.
   PubMed Web of Science ®Google Scholar
• Ovchinnikov, D. A., J. M. Deng, G. Ogunrinu, and R. R. Behringer. 2000. Col2a1-directed expression of Cre recombinase in differentiating chondrocytes in transgenic mice. Genesis 26:145–146.
   PubMed Web of Science ®Google Scholar
• Rentsendorj, O., A. Nagy, I. Sinkó, A. Daraba, E. Barta, and I. Kiss. 2005. Highly conserved proximal promoter element harbouring paired Sox9-binding sites contributes to the tissue- and developmental stage-specific activity of the matrilin-1 gene. Biochem. J. 389:705–716.
   PubMedGoogle Scholar
• Rimoin, D. L., D. Cohn, D. Krakow, W. Wilcox, R. S. Lachman, and Y. Alanay. 2007. The skeletal dysplasias: clinical-molecular correlations. Ann. N. Y. Acad. Sci. 1117:302–309.
   PubMedGoogle Scholar
• Rittenhouse, E., L. C. Dunn, J. Cookingham, C. Calo, M. Spiegelman, G. B. Dooher, and D. Bennett. 1978. Cartilage matrix deficiency (cmd): a new autosomal recessive lethal mutation in the mouse. J. Embryol. Exp. Morphol. 43:71–84.
   PubMedGoogle Scholar
• Roughley, P. 2006. The structure and function of cartilage proteoglycans. Eur. Cells Mater. 3012:92–101.
   Google Scholar
• Roughley, P., D. Martens, J. Rantakokko, M. Alini, F. Mwale, and J. Antoniou. 2006. The involvement of aggrecan polymorphism in degeneration of human intervertebral disc and articular cartilage. Eur. Cells Mater. 11:1–7.
   PubMed Web of Science ®Google Scholar
• Sakai, K., L. Hiripi, V. Glumoff, O. Brandau, R. Eerola, E. Vuorio, Z. Bosze, R. Fassler, and A. Aszodi. 2001. Stage- and tissue-specific expression of a Col2a1-Cre fusion gene in transgenic mice. Matrix Biol. 19:761–767.
   PubMedGoogle Scholar
• Salminen, H., E. Vuorio, and A. M. Säämänen. 2001. Expression of Sox9 and type IIA procollagen during attempted repair of articular cartilage damage in a transgenic mouse model of osteoarthritis. Arthritis Rheum. 44:947–955.
   PubMed Web of Science ®Google Scholar
• Sekiya, I., K. Tsuji, P. Koopman, H. Watanabe, Y. Yamada, K. Shinomiya, A. Nifuji, and M. Noda. 2000. SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J. Biol. Chem. 275:10738–10744.
   PubMed Web of Science ®Google Scholar
• Smits, P., P. Li, J. Mandel, Z. Zhang, J. M. Deng, R. R. Behringer, B. de Crombrugghe, and V. Lefebvre. 2001. The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev. Cell 1:277–290.
   PubMed Web of Science ®Google Scholar
• Smits, P., S. Mitra, and V. Lefebvre. 2004. Sox5 and Sox6 are needed to develop and maintain source, columnar and hypertrophic chondrocytes in the cartilage growth plate. J. Cell Biol. 164:747–758.
   PubMed Web of Science ®Google Scholar
• Valhmu, W. B., G. D. Palmer, J. Dobson, S. G. Fischer, and A. Ratcliffe. 1998. Regulatory activities of the 5′- and 3′-untranslated regions and promoter of the human aggrecan gene. J. Biol. Chem. 273:6196–6202.
   PubMedGoogle Scholar
• Valhmu, W. B., G. D. Palmer, P. A. Rivers, S. Ebara, J. F. Cheng, S. Fischer, and A. Ratcliffe. 1995. Structure of the human aggrecan gene: exon-intron organization and association with the protein domains. Biochem. J. 309:535–542.
   PubMedGoogle Scholar
• Watanabe, H., L. Gao, S. Sugiyama, K. Doege, K. Kimata, and Y. Yamada. 1995. Mouse aggrecan, a large cartilage proteoglycan: protein sequence, gene structure and promoter sequence. Biochem. J. 308:433–440.
   PubMedGoogle Scholar
• Watanabe, H., K. Kimata, S. Line, D. Strong, L. Y. Gao, C. A. Kozak, and Y. Yamada. 1994. Mouse cartilage matrix deficiency (cmd) caused by a 7 bp deletion in the aggrecan gene. Nat. Genet. 7:154–157.
   PubMedGoogle Scholar
• Watanabe, H., K. Nakata, K. Kimata, I. Nakanishi, and Y. Yamada. 1997. Dwarfism and age-associated spinal degeneration of heterozygote cmd mice defective in aggrecan. Proc. Natl. Acad. Sci. USA 94:6943–6947.
   PubMedGoogle Scholar
• Xie, W. F., X. Zhang, S. Sakano, V. Lefebvre, and L. J. Sandell. 1999. Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9. J. Bone Miner. Res. 14:757–763.
   PubMed Web of Science ®Google Scholar
• Zhao, Q., H. Eberspaecher, V. Lefebvre, and B. de Crombrugghe. 1997. Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev. Dyn. 209:377–386.
   PubMed Web of Science ®Google Scholar
• Zhou, G., G. Garofalo, K. Mukhopadhyay, V. Lefebvre, C. N. Smith, H. Eberspaecher, and B. de Crombrugghe. 1995. A 182 bp fragment of the mouse pro-alpha 1(II) collagen gene is sufficient to direct chondrocyte expression in transgenic mice. J. Cell Sci. 108:3677–3684.
   PubMedGoogle Scholar